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AN essential requisite of experimental oncology, if it is to have any applic-
ability to human cancer, is a host-tumour relationship approaching as closely as
possible that existing in autogenotis or spontaneous tumours. While trans-
plantation ofisogenic tumours within an inbred strain ofanimals has been assumed
to fiulfil this requirement, the immunogenetic identity of serially transmitted
tumiioutrs may diverge progressively from that of the host, eventually giving a
foreign " or immunizing tumour, too readily cured by facile procedures. The
occurrence of spontaneous mutations in serially transmitted tumours is, in fact,
one of the major pitfalls encountered in experimental cancer research (Hauschka,
19.52 Snell et al., 1946; Strong, 1949). It seems probable that many confusing
reports of resistance to isogenic titnioujrs arising in inbred strains can be ascribed
to this phenomenon.
AW!e have attempted to elimiinate this difficulty by restricting transplantation
to no more than one or two subpassages from the host of origin. In so doing
one requires a constant source of more or less identical spontaneous tumours, and
the C3H adenocarcinoma seemed entirely adequate in this respect. We have
found that autogenous mammary tuimoiurs arising in old females of the factor-
bearing C'3H/Cg strain have exhibited a constant morphology and radio-
sensitivity. These tumours have provided the source material for first and second
passage homoplasts, the latter constituting the pool of experimental tumours used
in this laboratory. In spite of these precautions, however, a spontaneous
mutation of a mammary tumour occurred at a first passage, the only instance thus
far detected in our series of 140 autogenous tumours transplanted into about 1500
recipient mice over a period of five years. As will be shown, the mutant, though
morphologically identical with the original tumour, exhibited a marked change in
radiosensitivity. It seemed that unless such an occurrence were recognised at the
outset, it might invalidate experimnents on the curability of any particular
transmitted tumour. The characteristics of this variant were therefore
investigated further and are described below. The term "mutation " is here
used to characterize this hereditary cellular change, without necessarily implying
a specific gene mutation.
MATERIALS AND METHODS.
Animals. As in the previous series of experiments, young mice of both sexes
of our factor-bearing substrain C3H/Cg were used.
Tumour. The mutation arose in a homoplast growinig in a mouse which had
been inoculated in a routine first-passage transmission with a fragment of anSPONTANEOUS MUTATION IN A HOMOPLAST
aultogenous mammary carcinoma from a female of this strain. Tumours borne by
co-recipients inoculated at the same time from the same source showed no obvious
changes. The mutant-tumour-bearing mouse was then inadvertently used as a
donor for a routine second passage, in which all the resultant tumours exhibited
the change. That a mutation had in fact arisen was indicated by the obviously
decreased latent period, increased growth rate, and markedly altered radio-
sensitivity of the tumour when treated in situ. Following these observations, the
tumour was transplanted through 8 successive passages, consistently displaying
the foregoing characteristics.
Of a total of 80 mice inoculated, the mutant tumour " took " in only 70 cases,
indicating an initial resistance rate of 121 per cent. This differs remarkably from
our standardised C3H tumour, in which failure of an inoculum to grow is an
extreme rarity, probably less than once in 1000 implants. By repeated challenge
of the initially resistant mice further successful " takes " were obtained in about
one-half of these animals.
On histological examination, the mutant tumour showed a general structure
iindistinguishable from that of our previously standardised C3H adenocarcinoma,
except for a greater nuimber of mitotic figures commensurate with its higher
growth rate.
Radiation factors. As in all previous experiments, roentgen rays generated at
240 kVp., with no added filters, HVL 0 34 mm. Cu, FSD 25 cm., were used. The
dose rate was 500r/min. for treatment in situ with the 2 cm. diameter applicator
(Cohen and Cohen, 1953).
Experimental design.-A total of 57 tumours ofthe mutant line were irradiated
in situ at 3-dose levels corresponding to those usedin previous series-4200r, 3500r,
and 3000r. The proportion of cures at each dose was tabulated (Table I) and
plotted on the log-probit graph (Fig. 1) for comparison with data previously
obtained for our standardised C3H tumour. On the analogy of a 6-point assay,
the magnitude and significance ofthe change in radiosensitivity was estimated by
standard statistical methods.
RESULTS.
[Fumotur size and growth rate.
The rate ofgrowth of this mutant tumour line was much more rapid than that
of the previously standardised tumour. The latent interval between the time of
implantation and the appearance ofa palpable "take " was generally under 7 days,
compared with a period of 7 to 15 days for the standard tumour. Similarly, the
interval between implantation and irradiation in this experiment ranged from 10
to 25 days, while the usual C3H tumour is rarely large enough for treatment
before the 30th day after implantation. Despite this short interval, the average
size of these tumours at the time of treatment was somewhat larger than that in
previously reported series. All tumours were roughly spheroidal in shape, and
their volumes were estimated by measurement at the time of treatment from the
formula V - 6 ab2, where a is the axial length and b the equatorial diameter ofthe
spheroid. The average tumour volume at treatment was about 1000 mm.3,
though at no time was a tumour greater than 2 cm. in its largest diameter, or more
than 4000 mm.3 in volume, used. Since larger tumours may be expected on
theoretical grounds to be less easily eradicated, the unavoidable discrepancy in
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size between the mutant and control groups actually enhances the significance of
the observations.
In order to compare growth rates we assumed an exponential increase (V.egt)
of tumour volume (V) with time in days (t), so that the growth constant (g) could
be estimated for each mouse from measurements of tumour size at treatment.
While the average value for the growth constant of our standard C3H tumour
growing in this strain ofC3H mouse is g =0.20 (±0-014) day-' (Cohen and Cohen,
1954a), the tumour doubling its volume approximately every 4 days, the growth of
the mutant line corresponds to a value of g = O-50 (± 0.04) day-1, this tumour
doubling its volume every 11 days. The mutant tumour thus grows about 21
times as rapidly as our standardised mammary carcinoma, a highly significant
ratio despite our relatively crude methods of measurement.
Radiosemsitivity.
The results of treatment in situ of the mutant line adenocarcinoma at three
dose levels are shown in Table I. It will be noted that a high proportion of cures is
obtained at a dose of only 4200r, and a few even at 3500r, although both these
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FIG. 1.-Probit diagram showing response ofthe mutant line adenocarcinoma (L) to irradiation
in 8itu compared with the standardised isogenic tumour in C3H mice (A) and in factor-free
F1 hybrid hosts (F).
doses are known to be completely ineffective when the usual standardised tumour
is treated in the C3H host. For the purpose of comparison, the data are shown in
the probit diagram (Fig. 1) together with the previously established regression
lines for our standard C3H control series and a factor-free F1 hybrid host.
Analysis of the data shows that the median effective dose for the mutant tumour
treated in situ is 3900r (± 40*), compared to 5700r for the control series. The
ratio of these factors, a measure of the difference in radiosensitivity, is 1.46
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(± 0.05*), indicating a highly significant increase (p < 0 0001) in radiosensitivity
of the mutant line. The coefficient of variation, as evidenced by the slope of the
line (line L, Fig. 1), is less than 10 per cent, indicating as consistent a response as
that obtained with the control series (line A, Fig. 1).
TABLE I.-Treatment In Situ of the Mutant Line
Adenocarcinoma in C3H Mice.
Cure rates
Dose Number Number Cures expected with
(r). or mice. cured. (per cent) non-mutant tumour.
4200 . 34 27 79 . <1 %
3500 13 . 2 15 . <001 %
3000 . 10 . 0 0
The response ofthe mutant tumour bears comparison with that obtained when
the C3H carcinoma is grown in factor-free (CBA x C3H)F1 hybrid hosts (Cohen
and Cohen, 1954a), as shown in Fig. 1 (line F). The median lethal doses and their
coefficients of variation are seen to be practically identical in the two cases.
Subsequent challenge with a second inoculum of the same mutant line in mice
which had been cured by irradiation resulted in active growth in all cases,
indicating that no absolute immunity to the tumour had been induced.
DISCUSSION.
The frequency oftumour mutation is such that continual variation seems to be
more the rule than the exception. A wide range ofrecognisable hereditable changes
in the character of transmitted tumours has been recorded and ascribed to genic
mutation, random variation, or selective adaptation. The greatest potentiality
for variation appears to exist where tumours are being transmitted through
heterozygous hosts partially or wholly alien to the strain of origin (Barrett and
Deringer, 1950, 1952; Barrett, Deringer and Hansen, 1953). However, even
isogenic tumour lines can differentiate either as a result of prolonged serial
transmission (Foley, 1952), or from the mutagenic action of the carcinogenic
hydrocarbon used to induce the primary growth, after only a few passages in the
inbred strain of origin (Foley, 1953).
Compared to the parent tumour, a mutant line may show one or more of the
following aberrations: a change in the proportion of successful takes on homoio-
transplantation; an increased rate of growth of the established tumour; an
increased tendency to metastasise; a loss of host specificity with the ability to
grow in relatively alien strains (Strong, 1949); a tendency to regress after trauma
and occasionally to induce absolute immunity to further implants of the same
tumour; transformation from one morphologic type to another (see Dunham and
Stewart's survey, 1953); acquisition of the facility to produce ascites (Klein and
Klein, 1951; Klein, 1955); shift in the modal value of chromosome number to
the tetraploid state (Hauschka and Levan, 1953); and, as we have shown, a
marked change in radiosensitivity.
The findings reported here illustrate a change that arose in an isogenic tumour
even when the host strain of origin was rigidly inbred and prolonged serial
* Standard error of median and of ratio of medians.
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transmission was avoided. The proportion of takes in the strain of origin was
significantly reduced, the curability was greatly enhanced with a general absence
of metastases, and a few immune mice observed, all indicating an increased
resistance onthe part ofthe host against this tumour. It is interesting to note that
the characteristics of the mutant were, in a sense, contradictory: the decreasedl
host susceptibility being associated with an increased growth rate. This
situation is reminiscent of the well-known clinical observation that the imiore
rapidly growing anaplastic tumours generally have a greater radiosensitivity.
Since none of the mice inoculated in the first passage showed any overt change
in growth rate or radiosensitivity, the original autogenous tumour used as the
source was probably no different from all others in this series ofexperiments. The
fact that all the tumours in the second passage were obviously atypical, indicates
that the mutation must have appeared suddenly after implantation ofthe tumour
into the particular mouse used as the donor for the second passage. The change
was obviously hereditary, persisting through eight transplant generations.
As previously described (Cohen and Cohen, 1954), even a minor antigenic
difference between host and tumour results in a perceptible increase in radio-
sensitivity. The present experiment demonstrates an increased radiosensitivity
as a result of spontaneous change in the character of tthe tumour transplant.
The fact that the radiosensitivity of the mutant tumour closely resembles that of
the originally standardised tumour grown in the factor-free F1 hybrid hosts,
suggests that the same degree of antigenic difference exists between the mutant
tumour and the homozygous host as between the isogenic tumour and a hetero-
zygous host. It appears that the radiosensitivity of a tumour is a delicate index
of host-tumour diversification, irrespective of whether the initial change occurs in
host or tumour. As previouly suggested (Cohen and Cohen, 1954c), the samne
immunological mechanism operates in both instances.
SUMMARY.
The characteristics of a sudden spontaneous mutation, occurring in onie first
passage C3H mouse mammary carcinoma homoplast, are described. On further
transmission, 124 per cent of the inbred C3H hosts were found to be initially
resistant to this tumour. The mutant tumour was morphologically similar to
other mammary tumours of the strain, but its growth rate was 24 times that of
non-mutant tumours. When treated in situ, the LD50 proved to be 3900r as
compared to 5700r of non-mutant tumours. The change appeared to be
permanent, the tumour displaying consistent behaviour through eight transplant
generations.
We are indebted to Dr. J. F. Murray for providing facilities at the South
African Institute for Medical Research where the C13H/Cg mouse colony is
maintained, and to Mrs. Shelley Jacobson for her invalulable skilled assistance in
the upkeep and breeding of this colony.
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